Lahcen Aït Bentaleb

Author

Lahcen Aït Bentaleb

Université de Montréal

Also Known As

L A Bentaleb, L Ait Bentaleb, L. Ait Bentaleb, Lahcen Ait Bentaleb, Lahcen Aït Bentaleb, Natalie Bertrand

Publications

554

Citations

H-Index

Concepts

All Affiliations

Université de Montréal Hôpital Louis-H Lafontaine Centre Hospitalier de l’Université de Montréal Hôpital Notre-Dame Polytechnique Montréal

About

Lahcen Aït Bentaleb is an author at Université de Montréal specializing in psychiatry, medicine, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	279
2	Social Sciences	7	7	279
3	Neuroscience	7	7	279
4	Pharmacology	2	2	68
5	Neurology	1	1	52

Lahcen Aït Bentaleb

Publications

484

Citations

H-Index

Page 1

	Year	Citations
Cerebral activity associated with auditory verbal hallucinations: a functional magnetic resonance imaging case study Lahcen Aït Bentaleb, Mario Beauregard, Peter F. Liddle, Journal of Psychiatry and Neuroscience	2002	93
Pain perception in schizophrenia: No changes in diffuse noxious inhibitory controls (DNIC) but a lack of pain sensitization Stéphane Potvin, Émmanuel Stip, Adrien Tempier, Journal of Psychiatric Research Pain SyndromePsychiatryPain MedicinePsychologySchizophrenia	2008	72
Restoration of frontal activation during a treatment with quetiapine: an fMRI study of blunted affect in schizophrenia Émmanuel Stip, Chérine Fahim, Adham Mancini‐Marïe, Progress in Neuro-Psychopharmacology and Biological Psychiatry PsychiatryPsychotic DisorderPsychotropic MedicationAffective NeurosciencePsychopharmacology	2004	53
Neural changes associated with appetite information processing in schizophrenic patients after 16 weeks of olanzapine treatment Émmanuel Stip, Ovidiu Lungu, Karyne Anselmo, Translational Psychiatry NeuropsychologyFood Information ProcessingPsychotropic MedicationPsychopharmacologyNeuropsychiatry	2012	52
Endocannabinoids and Schizophrenia Joëlle Desfossés, Émmanuel Stip, Lahcen Aït Bentaleb, Pharmaceuticals Membrane PrecursorsPsychosis HomeostasisPsychopharmacologySocial SciencesCannabinoids	2010	39
Neural Correlates of Sad Feelings in Schizophrenia with and without Blunted Affect Émmanuel Stip, Chérine Fahim, Peter F. Liddle, The Canadian Journal of Psychiatry	2005	32
Plasma Endocannabinoid Alterations in Individuals with Substance Use Disorder are Dependent on the “Mirror Effect” of Schizophrenia Joëlle Desfossés, Émmanuel Stip, Lahcen Aït Bentaleb, Frontiers in Psychiatry Substance UsePsychopharmacologyCannabinoid PharmacologySubstance Use DisordersPsychology	2012	29
Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia Simon Zhornitsky, Émmanuel Stip, Tania Pampoulova, Movement Disorders	2010	27
Working memory and depressive symptoms in patients with schizophrenia and substance use disorders Stéphane Potvin, Tania Pampoulova, Olivier Lipp, Cognitive Neuropsychiatry	2008	24
Are cholinergic enhancers beneficial for memory in schizophrenia? An event-related potentials (ERPs) study of rivastigmine add-on therapy in a crossover trial François Guillem, Sylvie Chouinard, Julie Poulin, Progress in Neuro-Psychopharmacology and Biological Psychiatry NeuropsychologyPsychiatryCrossover TrialMedicineDementia	2006	23

Page 1